JPWO2021208963A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021208963A5
JPWO2021208963A5 JP2022554627A JP2022554627A JPWO2021208963A5 JP WO2021208963 A5 JPWO2021208963 A5 JP WO2021208963A5 JP 2022554627 A JP2022554627 A JP 2022554627A JP 2022554627 A JP2022554627 A JP 2022554627A JP WO2021208963 A5 JPWO2021208963 A5 JP WO2021208963A5
Authority
JP
Japan
Prior art keywords
alkyl
heterocyclyl
cycloalkyl
optionally substituted
pharma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022554627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520843A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/087225 external-priority patent/WO2021208963A1/en
Publication of JP2023520843A publication Critical patent/JP2023520843A/ja
Publication of JPWO2021208963A5 publication Critical patent/JPWO2021208963A5/ja
Pending legal-status Critical Current

Links

JP2022554627A 2020-04-15 2021-04-14 Bcl-2阻害剤 Pending JP2023520843A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/084992 2020-04-15
CN2020084992 2020-04-15
CN2020100472 2020-07-06
CNPCT/CN2020/100472 2020-07-06
CN2020125580 2020-10-30
CNPCT/CN2020/125580 2020-10-30
CNPCT/CN2021/075831 2021-02-07
CN2021075831 2021-02-07
CN2021086189 2021-04-09
CNPCT/CN2021/086189 2021-04-09
PCT/CN2021/087225 WO2021208963A1 (en) 2020-04-15 2021-04-14 Bcl-2 inhibitor

Publications (2)

Publication Number Publication Date
JP2023520843A JP2023520843A (ja) 2023-05-22
JPWO2021208963A5 true JPWO2021208963A5 (de) 2024-04-16

Family

ID=78083530

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554627A Pending JP2023520843A (ja) 2020-04-15 2021-04-14 Bcl-2阻害剤

Country Status (13)

Country Link
US (1) US20230159522A1 (de)
EP (1) EP4136084A4 (de)
JP (1) JP2023520843A (de)
KR (1) KR20230002419A (de)
CN (3) CN116802179A (de)
AU (1) AU2021256580A1 (de)
BR (1) BR112022019525A2 (de)
CA (1) CA3172478A1 (de)
IL (1) IL296582A (de)
MX (1) MX2022013006A (de)
TW (1) TW202200574A (de)
WO (1) WO2021208963A1 (de)
ZA (1) ZA202209891B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022213335A1 (en) * 2021-04-09 2022-10-13 Beigene (Beijing) Co., Ltd. Method for preparing intermediate of bcl-2 inhibitor
WO2023078398A1 (en) * 2021-11-05 2023-05-11 Fochon Pharmaceuticals, Ltd. Compounds as bcl-2 inhibitors
CA3238781A1 (en) * 2021-11-20 2022-11-10 Hongbin Liu Compounds as bcl-2 inhibitors
AU2022406595A1 (en) * 2021-12-06 2024-05-16 Guangdong Hongye Pharmaceutical Co., Ltd. Anti-apoptotic protein bcl-2 inhibitor, pharmaceutical composition and uses thereof
WO2023122000A1 (en) * 2021-12-20 2023-06-29 Newave Pharmaceutical Inc. Bcl-2 inhibitors
CN114292192A (zh) * 2022-01-17 2022-04-08 山东泓瑞医药科技股份公司 一种3,4-二甲氧基苯甲酸甲酯的合成方法
AU2023235233A1 (en) 2022-03-14 2024-09-12 Slap Pharmaceuticals Llc Multicyclic compounds
WO2023231777A1 (en) * 2022-06-01 2023-12-07 Fochon Pharmaceuticals, Ltd. Compounds as bcl-2 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106749233B (zh) * 2016-11-24 2020-04-21 中山大学 一类磺酰胺衍生物及其应用
CN106809678B (zh) * 2017-01-03 2018-02-23 东莞理工学院 一种新旧smt接料带的粘接机
CA3098348A1 (en) * 2018-04-29 2019-11-07 Beigene, Ltd. Bcl-2 inhibitors
WO2020140005A2 (en) * 2018-12-29 2020-07-02 Newave Pharmaceutical Inc. Bcl-2 inhibitors
WO2022213335A1 (en) * 2021-04-09 2022-10-13 Beigene (Beijing) Co., Ltd. Method for preparing intermediate of bcl-2 inhibitor

Similar Documents

Publication Publication Date Title
JP5746631B2 (ja) ベンゾフラン誘導体
JP6211530B2 (ja) 含窒素複素環化合物
HRP20180371T1 (hr) Novi derivati piridina
JP5937674B2 (ja) 癌の治療用のpi3−キナーゼ阻害剤としてのクロメノン化合物
JPWO2021208963A5 (de)
RU2016129018A (ru) Производные оксиндола, их получение и терапевтическое применение при лечении заболеваний, связанных с амрк
RU2015108894A (ru) СОЕДИНЕНИЯ 4-ГЕТЕРОАРИЛЗАМЕЩЕННОЙ БЕНЗОЙНОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ RORгаммаТ И ИХ ПРИМЕНЕНИЯ
RU2017116598A (ru) Соединения и композиции для модуляции киназной активности мутантов egfr
RU2011107437A (ru) Ингибиторы кинуренин-3-моноксигеназы
RU2017146661A (ru) Замещенные пиридины и способ их применения
JP3922884B2 (ja) ベンゾフリルピロン誘導体
RU2014124950A (ru) Производные 2-фениламинопиримидина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2) для лечения болезни паркинсона
WO2013053051A1 (en) Indazole compounds as kinase inhibitors and method of treating cancer with same
JPWO2013161919A1 (ja) Trk阻害化合物
JP2015526441A5 (de)
JP2011511001A5 (de)
JP2014520885A5 (de)
JP2017523223A5 (de)
JP2019537590A5 (de)
JP2008528663A (ja) Ties(TEK)阻害活性を有するピリミジン化合物
JP2016514709A (ja) ヤヌスキナーゼ阻害剤としてのジェミナル置換シアノエチルピラゾロピリドン
RU2753524C2 (ru) Бициклические азотсодержащие гетероциклические производные и включающие их фармацевтические композиции
CN108069955B (zh) 3-吡啶基-4-苯并噻唑基吡唑类衍生物、其制备方法及其在医药上的应用
JP2008534481A (ja) インスリン様増殖因子−1受容体活性の阻害剤としての2−アゼチジニル−4−(1h−ピラゾール−3−イルアミノ)ピリミジン
JP2016515573A (ja) Cetp抑制活性を有する新規なオキサゾリジノン誘導体、その製造方法およびこれを含む薬学組成物